Insulin Resistance and Cognitive Impairment in Non-Diabetic Patients

다국어 초록 (Multilingual Abstract)

Background: Type 2 diabetes mellitus (DM2) is associated with cognitive impairment. Peripheral insulin resistance is known to be the major contributor to the progression of hyperglycemia and DM. However, the relationship between insulin resistance (IR) and the risk of cognitive decline in non-diabetic patients is not clear so far. Methods: We analyzed 18 Alzheimer disease (AD) patients, 19 mild cognitive impairment (MCI) patients, and 24 cognitively healthy controls without diabetes. We examined their demographic characteristics, current and past illness and Mini-Mental State Examination (MMSE). We also examined insulin resistance index (Homeostasis Model Assessment of Insulin Resistance, HOMA-IR) as an indicator of IR and a factor associated with cognitive decline. Results: Levels of HOMA-IR were significantly different among the 3 groups (p<0.05) and HOMA-IR levels detected in the AD group were higher than those in the MCI and control groups. They were negatively correlated with the MMSE (p<0.01) and significantly connected with the cognitive decline subjects (r=-0.351, p<0.01). Multiple regression analysis revealed that the level of HOMA-IR was independently associated with cognitive decline (p<0.05). Conclusions: HOMA-IR levels were related to cognitive decline and these results suggest that HOMA-IR may be an important risk factor of dementia.

참고문헌 (Reference)

1 Dubois B, "Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria" 6 : 734-746, 2007

2 Umegaki H, "Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration?" 39 : 8-10, 2010

3 Perterson RC, "Mild cognitive impairment as a diagnostic entity" 256 : 183-194, 2004

4 Bourdel-Marchasson I, "Insulin resistance, diabetes and cognitive function: consequences for preventative strategies" 36 : 173-181, 2010

5 Matsuzaki T, "Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study" 75 : 764-770, 2010

6 Geroldi C, "Insulin resistance in cognitive impairment: the InCHIANTI study" 62 : 1067-1072, 2005

7 Rasgon NL, "Insulin resistance and hippocampal volume in women at risk for Alzheimer’s disease" Neurobiol Aging 2009

8 Abbatecola AM, "Insulin resistance and executive dysfunction in older persons" 52 : 1713-1718, 2004

9 Neumann KF, "Insulin resistance and Alzheimer’s disease: molecular links & clinical implications" 5 : 438-447, 2008

10 Luchsinger JA, "Hyperinsulinemia and risk of Alzheimer disease" 63 : 1187-1192, 2004

11 Young SE, "Hyperinsulinemia and cognitive decline in a middle-aged cohort" 29 : 2688-2693, 2006

12 Matthews DR, "Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man" 28 : 412-419, 1985

13 Bruehl H, "Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistan. .ce" 32 : 487-493, 2010

14 van den Berg E, "Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study" 26 : 261-269, 2008

15 McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease" 34 : 939-944, 1984

16 Hallschmid M, "Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?" 52 : 2264-2269, 2009

17 Euser SM, "A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study" 59 : 1601-1607, 2010